We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$15.1B
AUM Growth
-$1.32B
(-8.1%)
Cap. Flow
-$1.84B
Cap. Flow
% of AUM
-12.19%
Top 10 Holdings %
Top 10 Hldgs %
6.07%
Holding
4,629
New
783
Increased
1,169
Reduced
1,303
Closed
1,222
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$66.7M |
| 2 |
MSCI
MSCI
|
+$54.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$46.5M |
| 4 |
ResMed
RMD
|
+$44.7M |
| 5 |
PPG Industries
PPG
|
+$43.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$74M |
| 2 |
L3Harris
LHX
|
+$69.6M |
| 3 |
Honeywell
HON
|
+$64.1M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$60.2M |
| 5 |
Wells Fargo
WFC
|
+$59.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.88% |
| 2 | Consumer Discretionary | 8.49% |
| 3 | Financials | 8.33% |
| 4 | Industrials | 8.18% |
| 5 | Healthcare | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNK
3026
DELISTED
Mallinckrodt plc
MNK
| $83.7K | ﹤0.01% |
+70,898
| New | +$252K |
|
3027
Progress Software
PRGS
$1.76B
| $83.5K | ﹤0.01% |
1,438
-4,912
| -77% | -$279K |
|
|
XXII
3028
22nd Century Group
XXII
$1.54M
| – | – |
0
| – | – |
|
3029
Veru
VERU
$44.8M
| $82.8K | ﹤0.01% |
6,960
-9,559
| -58% | -$112K |
|
|
GRFS
3030
Grifois
GRFS
$5.47B
| $82.7K | ﹤0.01% |
+9,032
| New | +$74.6K |
|
3031
Broadwind
BWEN
$121M
| $82.5K | ﹤0.01% |
21,585
+919
| +4% | +$3.84K |
|
3032
Maravai LifeSciences
MRVI
$864M
| $82.3K | ﹤0.01% |
6,618
-163,371
| -96% | -$2.21M |
|
3033
Getty Images
GETY
$121M
| $82K | ﹤0.01% |
+16,801
| New | +$96.2K |
|
|
SRTA
3034
Strata Critical Medical Inc
SRTA
$538M
| $80.9K | ﹤0.01% |
+20,525
| New | +$65.1K |
|
|
HEPS
3035
D-Market Electronic Services & Trading
HEPS
$1.05B
| $80.6K | ﹤0.01% |
47,960
+29,396
| +158% | +$33.8K |
|
3036
Advantage Solutions
ADV
$387M
| $80.1K | ﹤0.01% |
1,369
+626
| +84% | +$26.8K |
|
3037
iHeartMedia
IHRT
$419M
| $79.8K | ﹤0.01% |
+21,928
| New | +$72.9K |
|
3038
Advanced Drainage Systems
WMS
$10.8B
| $79.6K | ﹤0.01% |
+700
| New | +$66.1K |
|
3039
American Well
AMWL
$226M
| $79.1K | ﹤0.01% |
1,882
+1,079
| +134% | +$47.6K |
|
3040
CBIZ
CBZ
$2.97B
| $78.8K | ﹤0.01% |
1,479
-18,808
| -93% | -$968K |
|
|
EA
3041
CALL
DELISTED
Electronic Arts
EA
| $77.8K | ﹤0.01% |
+600
| New | +$76K |
|
3042
VistaGen Therapeutics
VTGN
$11.8M
| $77.3K | ﹤0.01% |
+41,363
| New | +$145K |
|
3043
Sutro Biopharma
STRO
$414M
| $76.8K | ﹤0.01% |
1,652
-11,631
| -88% | -$579K |
|
3044
Latham Group
SWIM
$881M
| $76.7K | ﹤0.01% |
20,663
-30,864
| -60% | -$94.3K |
|
3045
Puma Biotechnology
PBYI
$455M
| $76.6K | ﹤0.01% |
21,692
-116,486
| -84% | -$363K |
|
3046
Ginkgo Bioworks
DNA
$506M
| $76.3K | ﹤0.01% |
1,025
-14,074
| -93% | -$833K |
|
|
OPTU
3047
Optimum Communications Inc
OPTU
$319M
| $76.1K | ﹤0.01% |
+25,200
| New | +$71.6K |
|
|
IRD
3048
Opus Genetics
IRD
$315M
| $75.3K | ﹤0.01% |
+17,355
| New | +$82.4K |
|
3049
Carpenter Technology
CRS
$27.1B
| $74.9K | ﹤0.01% |
1,335
-2,365
| -64% | -$116K |
|
|
KNDI
3050
Kandi Technologies Group
KNDI
$61.8M
| $73.8K | ﹤0.01% |
+18,638
| New | +$63K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q2 2023 Portfolio in Review
As of Q2 2023, Cubist Systematic Strategies held 4,629 positions worth $15.1B, down 8.1% from $16.4B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.
Cubist Systematic Strategies withdrew a net $1.84B in Q2 2023, closing 1,222 positions and reducing 1,303 holdings. Its most notable exit was Cigna, an estimated $74M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Cubist Systematic Strategies opened a new position in Atlassian worth $34.2M.
- Cubist Systematic Strategies's largest Q2 2023 buy was Atlassian: 203,897 shares worth $34.2M.
- Cubist Systematic Strategies added most to Alphabet (Google) Class A in Q2 2023, an estimated $66.7M increase.
- Cubist Systematic Strategies's biggest Q2 2023 reduction was L3Harris, cutting an estimated $69.6M.
- Cubist Systematic Strategies fully exited Cigna in Q2 2023, selling an estimated $74M.
- Cubist Systematic Strategies's ten largest holdings make up 6.1% of its $15.1B portfolio in Q2 2023.
- Cubist Systematic Strategies opened 783 new positions and closed 1,222 in Q2 2023.
- Cubist Systematic Strategies's portfolio value fell 8.1% quarter-over-quarter to $15.1B.
Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.